Search Results
Found 2 results
510(k) Data Aggregation
(222 days)
LUNG FLUTE THERAPEUTIC
The Lung Flute® Therapeutic is indicated for Positive Expiratory Pressure (PEP) therapy.
The Lung Flute® Therapeutic is shaped like a pipe or flute with a plastic mouthpiece at one end. A Mylar reed is attached inside a square hardened plastic tube that flairs on the end to increase the internal air mass, which provides acoustical impedance. When the patient exhales through the "flute-like" device, the reed inside the tube oscillates and acts in tandem with the rest of the device and the lung cavity itself to produce a sound frequency that approximates the resonance frequency of pulmonary secretions. The Lung Flute® Therapeutic facilitates mucus clearing by generating and delivering a specific low frequency sound that vibrates the airways and lung secretions, causing lung secretions to thin and become expelled.
1. Table of Acceptance Criteria and Reported Device Performance
Acceptance Criteria | Reported Device Performance |
---|---|
Similar sputum amounts compared to predicate | Lung Flute® Therapeutic produced similar amounts of sputum compared to Acapella. |
Similar spirometry performance compared to predicate | Lung Flute® Therapeutic performed similarly on spirometry compared to Acapella. |
Similar questionnaire results (CCQ and SGRQ) compared to predicate | Lung Flute® Therapeutic performed similarly on Chronic COPD Questionnaire (CCQ) and St. Georges Respiratory Questionnaire (SGRQ) compared to Acapella. |
Similar daily diary recordings (breathlessness, cough, sputum scale) compared to predicate | Similar daily diary recordings of breathlessness, cough, and sputum scale (BCSS) were maintained. |
Similar daily emergency inhaler use compared to predicate | Similar daily use of emergency inhaler was recorded. |
Note: The document explicitly states "Performance standards have not been established by the FDA under section 514 of the Federal, Food, Drug and Cosmetic Act." Therefore, the acceptance criteria are implicitly derived from demonstrating substantial equivalence to the predicate device, Acapella.
2. Sample Size Used for the Test Set and Data Provenance
The document does not explicitly state the exact sample size for the clinical study (test set). It mentions "A cohort of chronic bronchitic patients". The provenance of the data (country of origin, retrospective or prospective) is also not specified.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications
This information is not applicable. The device is a therapeutic device for mucus clearing, not a diagnostic device requiring expert interpretation for ground truth establishment. The performance was assessed through objective and patient-reported measures, not expert annotation.
4. Adjudication Method for the Test Set
This information is not applicable as the study did not involve expert adjudication of results.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
This information is not applicable. The device is a therapeutic device, not an AI-assisted diagnostic tool for human readers.
6. If a Standalone (i.e. algorithm only without human-in-the loop performance) was done
This information is not applicable. The device is a physical therapeutic device used by a patient, not an algorithm.
7. The Type of Ground Truth Used
The "ground truth" or primary measures of effectiveness were:
- Sputum samples weighed: Objective physiological measurement.
- Spirometry performance: Objective physiological measurement.
- Chronic COPD Questionnaire (CCQ) and St. Georges Respiratory Questionnaire (SGRQ): Patient-reported outcomes.
- Daily diary recordings of breathlessness, cough, and sputum scale (BCSS): Patient-reported outcomes.
- Daily use of emergency inhaler: Patient-reported outcome/behavioral measure.
8. The Sample Size for the Training Set
This information is not applicable. The device is a physical therapeutic device, not an AI model that requires a training set.
9. How the Ground Truth for the Training Set was Established
This information is not applicable, as there is no training set for this type of device.
Ask a specific question about this device
(121 days)
LUNG FLUTE
The LUNG FLUTE™ is indicated for the collection of sputum samples for laboratory analysis and pathologic examination.
The LUNG FLUTE™ is shaped like a pipe or flute with a plastic mouthpiece at one end. A Mylar reed is attached inside a square hardened plastic tube that flairs on the end to increase the internal air mass, which provides acoustical impedance. When the patient exhales through the "flute-like" device, the reed inside the tube oscillates and acts in tandem with the rest of the device and the lung cavity itself to produce a sound frequency that approximates the resonance frequency of pulmonary secretions. The LUNG FLUTE™ facilitates mucus clearing by generating and delivering a specific low frequency sound that vibrates the airways and lung secretions, causing lung secretions to thin and become expelled.
The provided text describes the LUNG FLUTE™ device and its clinical performance study. Here's an analysis of the requested information based on the given text:
Acceptance Criteria and Study Details for LUNG FLUTE™ (K060439)
The LUNG FLUTE™ is a device designed to facilitate mucus clearing by generating a specific low-frequency sound, primarily indicated for the collection of sputum samples for laboratory analysis and pathologic examination.
1. Table of Acceptance Criteria and Reported Device Performance
Acceptance Criteria (Implicit) | Reported Device Performance |
---|---|
Sputum samples collected by the LUNG FLUTE™ should contain biomarkers indicative of lower respiratory tract samples. | A cohort of chronic bronchitis patients underwent sputum induction using the LUNG FLUTE™. Sputum samples were analyzed for biomarkers (Neutrophil, Macrophages, Squamous Cells, Interleukin-8, Fibrinogen, and Elastase). Salivary samples (representing upper respiratory tract) were also analyzed. |
Biomarker concentrations in LUNG FLUTE™ induced sputum samples should be similar to those obtained via nebulized hypertonic saline (predicate device). | The LUNG FLUTE™ and nebulized hypertonic saline produced similar concentrations for Neutrophils, Macrophages, Squamous Cells, and Interleukin-8. |
Biomarker concentrations in LUNG FLUTE™ induced sputum samples should be significantly different from salivary samples (to distinguish lower vs. upper respiratory tract). | Concentrations of Neutrophils, Macrophages, Squamous Cells, and Interleukin-8 in LUNG FLUTE™ induced sputum were significantly different from saliva. |
The device should be substantially equivalent to the predicate device (sputum induction by nebulized hypertonic saline) based on clinical performance. | Conclusion: Biomarkers found in sputum from samples obtained by nebulized hypertonic saline were similar to those found in sputum samples obtained using the LUNG FLUTE™. Based on this clinical performance, the LUNG FLUTE™ is considered substantially equivalent to sputum induction by nebulized hypertonic saline. |
2. Sample Size Used for the Test Set and Data Provenance
- Sample Size: "A cohort of chronic bronchitis patients" was used. The exact number of patients is not specified in the provided text.
- Data Provenance: The text does not explicitly state the country of origin. It describes a clinical study being submitted for FDA approval in the US. The study appears to be prospective as it involved patients undergoing sputum induction for comparison.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts
There is no mention of experts used to establish ground truth in the traditional sense, as this study focuses on objective biomarker analysis. Laboratory analysis was performed on the collected sputum and salivary samples. The qualifications of the individuals who performed the laboratory analysis are not specified.
4. Adjudication Method for the Test Set
There is no mention of an adjudication method in the provided text. The evaluation relied on quantitative biomarker analysis and statistical comparison.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done, If So, What Was the Effect Size of How Much Human Readers Improve with AI vs Without AI Assistance
A Multi-Reader Multi-Case (MRMC) comparative effectiveness study was not conducted as the LUNG FLUTE™ is a device for sputum collection, not an AI or imaging diagnostic tool that would involve human readers.
6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done
This question is not applicable as the LUNG FLUTE™ is a physical medical device, not an algorithm or AI system. Its performance is evaluated by the characteristics of the sputum it helps collect.
7. The Type of Ground Truth Used (expert consensus, pathology, outcomes data, etc.)
The ground truth used was biomarker analysis of sputum and salivary samples. This is a form of objective laboratory data, not expert consensus or pathology on its own (though pathology would be performed on the collected sputum after collection). The comparison was made against a well-established method (nebulized hypertonic saline) and control samples (saliva).
8. The Sample Size for the Training Set
There is no mention of a training set. This study describes a clinical trial evaluating the performance of a medical device, not the development or training of an algorithm.
9. How the Ground Truth for the Training Set Was Established
This question is not applicable as there was no mention of a training set for an algorithm.
Ask a specific question about this device
Page 1 of 1